Cargando…

Risco de resultado falso positivo no rastreamento mamográfico do Brasil

False-positive results on mammography screening are common, putting a burden on both women and the health care system. This study aimed to estimate the risk of false-positive results in Brazilian mammography screening based on data from the Brazilian Unified National Health System (SUS) information...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Renata Oliveira Maciel, de Assis, Mônica, Dias, Maria Beatriz Kneipp, Tomazelli, Jeane Glaucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641911/
https://www.ncbi.nlm.nih.gov/pubmed/37255192
http://dx.doi.org/10.1590/0102-311XPT117922
_version_ 1785146852494016512
author dos Santos, Renata Oliveira Maciel
de Assis, Mônica
Dias, Maria Beatriz Kneipp
Tomazelli, Jeane Glaucia
author_facet dos Santos, Renata Oliveira Maciel
de Assis, Mônica
Dias, Maria Beatriz Kneipp
Tomazelli, Jeane Glaucia
author_sort dos Santos, Renata Oliveira Maciel
collection PubMed
description False-positive results on mammography screening are common, putting a burden on both women and the health care system. This study aimed to estimate the risk of false-positive results in Brazilian mammography screening based on data from the Brazilian Unified National Health System (SUS) information systems. A retrospective cohort study was conducted with women aged 40-69 years, who underwent mammography screening and breast histopathological examination at SUS from 2017 to 2019. The rate of false-positive results was estimated based on the prevalence of altered BI-RADS results on mammography screening and the proportion of benign results on breast histopathological examination. Of the 10,671 women with histopathological examination at SUS, 46.2% had a benign result, and this proportion was significantly higher in women aged 40-49 years compared to women aged 50-69 years. The estimate of false-positive results was 8.18 cases per 100 women aged 40-49 years and 6.06 per 100 women aged 50-69 years. This information is useful for public managers in evaluating mammography screening programs, as well as for health care providers to guide women on the implications of mammography screening.
format Online
Article
Text
id pubmed-10641911
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
record_format MEDLINE/PubMed
spelling pubmed-106419112023-11-14 Risco de resultado falso positivo no rastreamento mamográfico do Brasil dos Santos, Renata Oliveira Maciel de Assis, Mônica Dias, Maria Beatriz Kneipp Tomazelli, Jeane Glaucia Cad Saude Publica Artigo False-positive results on mammography screening are common, putting a burden on both women and the health care system. This study aimed to estimate the risk of false-positive results in Brazilian mammography screening based on data from the Brazilian Unified National Health System (SUS) information systems. A retrospective cohort study was conducted with women aged 40-69 years, who underwent mammography screening and breast histopathological examination at SUS from 2017 to 2019. The rate of false-positive results was estimated based on the prevalence of altered BI-RADS results on mammography screening and the proportion of benign results on breast histopathological examination. Of the 10,671 women with histopathological examination at SUS, 46.2% had a benign result, and this proportion was significantly higher in women aged 40-49 years compared to women aged 50-69 years. The estimate of false-positive results was 8.18 cases per 100 women aged 40-49 years and 6.06 per 100 women aged 50-69 years. This information is useful for public managers in evaluating mammography screening programs, as well as for health care providers to guide women on the implications of mammography screening. Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz 2023-05-26 /pmc/articles/PMC10641911/ /pubmed/37255192 http://dx.doi.org/10.1590/0102-311XPT117922 Text en https://creativecommons.org/licenses/by/4.0/Este é um artigo publicado em acesso aberto sob uma licença Creative Commons
spellingShingle Artigo
dos Santos, Renata Oliveira Maciel
de Assis, Mônica
Dias, Maria Beatriz Kneipp
Tomazelli, Jeane Glaucia
Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title_full Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title_fullStr Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title_full_unstemmed Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title_short Risco de resultado falso positivo no rastreamento mamográfico do Brasil
title_sort risco de resultado falso positivo no rastreamento mamográfico do brasil
topic Artigo
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641911/
https://www.ncbi.nlm.nih.gov/pubmed/37255192
http://dx.doi.org/10.1590/0102-311XPT117922
work_keys_str_mv AT dossantosrenataoliveiramaciel riscoderesultadofalsopositivonorastreamentomamograficodobrasil
AT deassismonica riscoderesultadofalsopositivonorastreamentomamograficodobrasil
AT diasmariabeatrizkneipp riscoderesultadofalsopositivonorastreamentomamograficodobrasil
AT tomazellijeaneglaucia riscoderesultadofalsopositivonorastreamentomamograficodobrasil